Andrea Lobo,  —

NeuroPoint Alliance’s (NPA) registry for people with Parkinson’s disease eligible for deep brain stimulation (DBS) surgery announced that it has completed its initial pilot phase, collecting information on more than 170 patients who underwent the treatment. Called the Registry for the Advancement of DBS in Parkinson’s Disease, or…

Heavier coffee drinkers, based on the number of cups consumed daily, have a lower volume of the striatum, a brain region affected in Parkinson’s disease, whether or not they have Parkinson’s, a study from China using MRI data reported. Regular coffee consumption, without an emphasis on cups per day,…

Women with Parkinson’s disease are less likely to be referred for deep brain stimulation (DBS) evaluation than men, a study has found. Moreover, women with essential tremor, a disease that shares symptoms with Parkinson’s and can also be treated with DBS, were more likely to decline surgery, once approved.

Home initiation of under-the-skin (subcutaneous) apomorphine infusion — a treatment for motor fluctuations — is faster at improving the life quality of Parkinson’s disease patients than in hospital initiation, a French study has shown. Continuous subcutaneous apomorphine infusion (CSAI) initiation at home for Parkinson’s was found to be feasible…

Physical exercise interventions can lessen Parkinson’s disease motor symptoms — and these beneficial effects are similar for both aerobic and nonaerobic activity. That’s according to the findings of a new meta-analysis of published studies, which involved 25 articles relating to interventions spanning 4-26 weeks. “This review provides…

Teitur Trophics has raised €28 million (about $29.7 million) to advance its lead candidate, TT-P34, into a Phase 1b clinical trial as a possible treatment for Parkinson’s and other neurodegenerative diseases. “There is a pressing need for new therapies for neurodegenerative diseases which have a detrimental impact on…

Researchers have found a genetic association between Parkinson’s disease and melanoma, a type of skin cancer, and prostate cancer. Data also showed that Parkinson’s genetic risk factors are linked to an increased risk of breast cancer and lower risk of ovarian cancer. “Our results suggest the importance of shared genetic…

Inbrija (levodopa inhalation powder), an approved therapy for off episodes in Parkinson’s patients on certain standard levodopa-based treatments, is now available in Spain. Developed by Acorda Therapeutics, the therapy was approved in the U.S. in 2018 and for the European Union in 2019. In Spain and Germany — where…

Older Parkinson’s patients undergoing deep brain stimulation (DBS), those in their 60s and 70s at the time of the surgical procedure, as well as those diagnosed at older ages are at a higher risk of death over the following years, according to a nationwide study in South Korea.

Men with mild-to-moderate Parkinson’s disease may experience greater effects of the disease on certain aspects of their life than women, according to a study of patients living in the southeastern U.S. Specifically, men were found to have worse motor symptoms, daily life-related impairments, disease-related quality of life, and more…